2007: Pediatric Rheumatology: From Genes to Cells

Pediatric Rheumatology: From Genes to Cells

Saturday, November 10, 2007

1707

Disease-Associated CIAS1 Mutations Induce Monocyte Death, Revealing Low-Level Mosaicism in Mutation-Negative Cryopyrin-Associated Periodic Syndrome Patients

1708

Seasonal Clustering of Symptom Onset in the Juvenile Spondyloarthropathies

1709

Gene Expression Patterns in Peripheral Blood Mononuclear Cells Identify Biological Differences Between JIA Subtypes

1710

A Systems Biology Approach to JIA: Gene Expression Profiling Detects Only Small Differences between Children with Pauciarticular and Polyarticular Disease

1711

The Biological Meaning of Clinical Remission in JIA: A Systems Biology Approach

1712

Tumor Necrosis Factor Alpha -308 GA/AA Genotypes are Associated with the Polyarticular Subtype of Juvenile Idiopathic Arthritis

1713

Effect on Anti-TNF Agents on Gene Expression in Children with Juvenile Arthritis

1714

Mutations of the HLH-Associated Gene UNC13D (MUNC13-4) in a Patient with Systemic Onset Juvenile Idiopathic Arthritis

1715

Synovial Fluid Proteins Differentiate Between Subtypes of Juvenile Idiopathic Arthritis

1716

Characterization of Protein Expression Profiles in Circulating Immune Complexes (CICs) from Juvenile Idiopathic Arthritis (JIA)

1717

Il-17 Levels are Elevated in Synovial Fluid of Patients with JIA and It Induces Production of Cytokines and MMPs by Fibroblast like Synoviocytes

1718

Serum and Synovial Fluid Concentrations of Interleukin-23 and Interleukin-17 in Juvenile Idiopathic Arthritis

1719

Synovial Fluid T Cells are Resistant to rAd Based Suppression of Proliferation

1720

Role of Vγ9Vδ2+ γδ T Cells in Juvenile Idiopathic Arthritis

1721

Clonal Expansion of Synovial B Cells and Differentiation into Plasma Cells in Juvenile Idiopathic Arthritis

1722

Decreased Proportion of Thymic Recent Emigrants in Juvenile Idiopathic Arthritis

1723

Study of Thymic Size and Function in Children and Adolescents with Treatment Refractory Systemic Sclerosis Eligible for Immunoablative Therapy

1724

Pathway Analysis of Genes Differentially Expressed in Peripheral Blood Mononuclear Cells from Children with Stable, Flaring or Improving Systemic Lupus Erythematosus

1725

Gene Expression Profiles in Neutrophils of Children with SLE: Abnormal Regulation of Apoptosis-Related Genes Suggests Role for Neutrophils in SLE

1726

Low Expression of Fas and Bcl-2 Proteins on Peripheral Monocytes from Juvenile-Onset Systemic Lupus Erythematosus

1727

Ro52 Autoantibodies Specific for Amino Acid 200-239 Bind Cardiomyocytes and Induce Atrioventricular Block in Rat Pups

1728

Inhibition of Matrix Metalloproteinase-9 Activity Improves Coronary Outcome in a Murine Model of Kawasaki Disease

1729

Elastin Signalling in a Mouse Model of Kawasaki Disease

1730

HMG-CoA Reductase Inhibition Reduces T-cell Proliferation and MMP-9 Gene Expression in a Superantigenic Mouse Model of Kawasaki Disease

1731

Mannose Binding Lectin (MBL) Polymorphisms and Age at Onset of Kawasaki Disease (KD)

1732

Absence of Killer Ig-like Inhibitory Receptor with the Associated HLA Ligand in Juvenile Dermatomyositis

1733

Gene Expression Profiling in Neutrophils and PBMC in Juvenile Dermatomyositis

See more of: ACR Abstract Submission Poster Sessions

<< Previous Session Level | Next Session Level >>